Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Eagle Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −13 vs. Q4 2023
- Shares held
- 10.5M
- +433.8K (+4.3%) vs. Q4 2023
- Total value
- $54.8M
- +$2.38M (+4.5%) vs. Q4 2023
- New holders
- 16
- 25 more added
- Sold out
- 29
- 37 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $8.28K |
| Q1 2026 | 2 | $4.21K |
| Q4 2025 | 2 | $8.64K |
| Q3 2025 | 2 | $33.3K |
| Q2 2025 | 2 | $35.8K |
| Q1 2025 | 2 | $12.1K |
| Q4 2024 | 9 | $38.8K |
| Q3 2024 | 65 | $31.9M |
| Q2 2024 | 75 | $55.5M |
| Q1 2024 | 91 | $54.8M |
| Q4 2023 | 104 | $52.4M |
| Q3 2023 | 108 | $162.9M |
| Q2 2023 | 126 | $209.5M |
| Q1 2023 | 153 | $334.2M |
| Q4 2022 | 152 | $337.9M |
| Q3 2022 | 154 | $303.7M |
| Q2 2022 | 164 | $515.8M |
| Q1 2022 | 160 | $555.1M |
| Q4 2021 | 162 | $573.2M |
| Q3 2021 | 151 | $659.5M |
| Q2 2021 | 146 | $516.0M |
| Q1 2021 | 155 | $508.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Eagle Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 0 | $0 | 0.00% | −25,751−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,626−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −21,500−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −20,867−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −19,358−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −16,451−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,228−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,922−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −12,373−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,917−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −6,543−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,827−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Point72 Europe (London) LLP | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −59−100.0% | Sold out |